Clinuvel Of Australia Developing 'UV Vaccine' Drug For Fair-Skinned
This article was originally published in PharmAsia News
Executive Summary
Australia's Clinuvel expects to soon bring to the market its afamelanotide drug it calls a "UV vaccine" to protect fair-skinned people against the sun